Prospective, Randomized, open label, European, multicenter study of the efficacy of the linezolid-rifampin combination versus standard of care in the treatment of Gram-positive prosthetic hip joint infection
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Linezolid (Primary) ; Linezolid (Primary) ; Rifampicin; Rifampicin
- Indications Gram-positive infections
- Focus Therapeutic Use
- Acronyms LIZ-BONE
- 16 Jun 2016 Status changed from recruiting to completed.
- 07 Apr 2014 Planned End Date changed from 1 Oct 2016 to 1 Apr 2016 as reportd by ClinicalTrials.gov.
- 30 Dec 2012 Planned end date changed from 8 Apr 2016 to 1 Oct 2016 as reportd by ClinicalTrials.gov.